Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased

Daily Values

Growth Metrics

Others

Tandem Diabetes Care (TNDM) Change in Intangibles (2020)

Tandem Diabetes Care filings provide 4 years of Change in Intangibles readings, the most recent being $81000.0 for Q3 2020.

On a quarterly basis, Change in Intangibles changed N/A to $81000.0 in Q3 2020 year-over-year; TTM through Sep 2021 was $81000.0, a 0.0% change, with the full-year FY2020 number at $4.9 million, changed N/A from a year prior.
Change in Intangibles hit $81000.0 in Q3 2020 for Tandem Diabetes Care, up from $74000.0 in the prior quarter.
In the past five years, Change in Intangibles ranged from a high of $81000.0 in Q3 2020 to a low of $81000.0 in Q3 2020.